Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PYROTINIB Cause Palmar-plantar erythrodysaesthesia syndrome? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Palmar-plantar erythrodysaesthesia syndrome have been filed in association with PYROTINIB. This represents 11.4% of all adverse event reports for PYROTINIB.

28
Reports of Palmar-plantar erythrodysaesthesia syndrome with PYROTINIB
11.4%
of all PYROTINIB reports
2
Deaths
1
Hospitalizations

How Dangerous Is Palmar-plantar erythrodysaesthesia syndrome From PYROTINIB?

Of the 28 reports, 2 (7.1%) resulted in death, 1 (3.6%) required hospitalization.

Is Palmar-plantar erythrodysaesthesia syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PYROTINIB. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does PYROTINIB Cause?

Myelosuppression (62) Diarrhoea (57) Vomiting (39) Nausea (35) Alanine aminotransferase increased (32) Anaemia (28) Aspartate aminotransferase increased (26) Hypokalaemia (25) White blood cell count decreased (25) Fatigue (22)

What Other Drugs Cause Palmar-plantar erythrodysaesthesia syndrome?

CAPECITABINE (5,294) CABOZANTINIB S-MALATE (2,706) REGORAFENIB (1,230) LENVATINIB (1,211) BEVACIZUMAB (1,079) SORAFENIB (1,040) OXALIPLATIN (980) SUNITINIB MALATE (929) TRASTUZUMAB (919) FLUOROURACIL (837)

Which PYROTINIB Alternatives Have Lower Palmar-plantar erythrodysaesthesia syndrome Risk?

PYROTINIB vs QSYMIA PYROTINIB vs QUETIAPINE PYROTINIB vs QUINACRINE PYROTINIB vs QUINAPRIL PYROTINIB vs QUINAPRIL\QUINAPRIL

Related Pages

PYROTINIB Full Profile All Palmar-plantar erythrodysaesthesia syndrome Reports All Drugs Causing Palmar-plantar erythrodysaesthesia syndrome PYROTINIB Demographics